PMC:7243778 / 25925-26779
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
639 | 777-778 | Gene | denotes | S | Gene:43740568 |
640 | 350-351 | Gene | denotes | S | Gene:43740568 |
641 | 46-54 | Species | denotes | SARS-CoV | Tax:694009 |
642 | 59-67 | Species | denotes | MERS-CoV | Tax:1335626 |
643 | 192-200 | Species | denotes | SARS-CoV | Tax:694009 |
644 | 201-209 | Species | denotes | patients | Tax:9606 |
645 | 245-255 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
646 | 297-305 | Species | denotes | SARS-CoV | Tax:694009 |
647 | 339-349 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
648 | 456-464 | Species | denotes | SARS-CoV | Tax:694009 |
649 | 498-508 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
650 | 674-684 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
651 | 479-487 | Species | denotes | MERS-CoV | Tax:1335626 |
652 | 120-140 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
653 | 148-156 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T112 | 32-40 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T113 | 167-172 | Body_part | denotes | Serum | http://purl.org/sig/ont/fma/fma63083 |
T114 | 352-359 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T115 | 536-544 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T116 | 576-586 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
T117 | 715-725 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
T118 | 779-786 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T4 | 167-172 | Body_part | denotes | Serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T102 | 46-54 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T103 | 120-128 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T104 | 131-140 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T105 | 148-156 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T106 | 192-200 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T107 | 245-253 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T108 | 297-305 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T109 | 339-347 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T110 | 456-464 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T111 | 498-506 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T112 | 674-682 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T113 | 759-762 | Disease | denotes | NTD | http://purl.obolibrary.org/obo/MONDO_0008449|http://purl.obolibrary.org/obo/MONDO_0018075 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T321 | 105-111 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
T322 | 736-738 | http://purl.obolibrary.org/obo/CLO_0054055 | denotes | 71 |
T323 | 788-790 | http://purl.obolibrary.org/obo/CLO_0001627 | denotes | aa |
T324 | 850-852 | http://purl.obolibrary.org/obo/CLO_0001527 | denotes | 94 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T143 | 32-40 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T144 | 352-359 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T145 | 545-552 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
T146 | 576-586 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
T147 | 576-581 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T148 | 582-586 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T149 | 715-725 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
T150 | 715-720 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T151 | 721-725 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T152 | 779-786 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T202 | 0-166 | Sentence | denotes | Due to the high similarity of S proteins from SARS-CoV and MERS-CoV [73], their specific cross-nAbs were tested against SARS-CoV-2 infection in the COVID-19 outbreak. |
T203 | 167-311 | Sentence | denotes | Serum Abs from recovered SARS-CoV patients could efficiently cross-neutralize SARS-CoV-2 but with lower efficiency as compared to SARS-CoV [92]. |
T204 | 312-395 | Sentence | denotes | Cross-reactive Abs against SARS-CoV-2 S protein mostly target non-RBD regions [93]. |
T205 | 396-571 | Sentence | denotes | Using simulation technique, the binding of five Abs against SARS-CoV, six Abs anti-MERS-CoV to RBD of SARS-CoV-2 was predicted with Rosetta antibody-antigen docking protocols. |
T206 | 572-685 | Sentence | denotes | The amino acid position 445–449 (VGGNY) and 470–486 (TEIYQAGSTPCNGVEGF) were found to be conserved in SARS-CoV-2. |
T207 | 686-854 | Sentence | denotes | Moreover, in addition to the amino acid positions 71–77 (GTNGTKR) in the NTD region of the S protein, aa 445–449 and 470–486 are potential for further development [94]. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32450171-32015507-66454511 | 69-71 | 32015507 | denotes | 73 |